-- 根据周二提交给澳大利亚和新西兰证券交易所的文件,Ventia Services Group(澳交所代码:VNT,新西兰证券交易所代码:VNT)已获得维多利亚州交通与规划部的新合同,将根据维多利亚州道路维护合同模式,在格兰屏地区和东部都市区提供道路维护服务。 文件显示,这些合同的总价值约为3.4亿澳元,基本期限为四年,涵盖日常维护、计划维护项目和小型基建工程,具体内容取决于政府预算审批和道路优先事项。 文件还指出,这些协议还提供了格兰屏地区最多两年和东部都市区最多四年的延期选择权。 文件补充道,该公司将从7月1日起,为乡村和都市干道提供全面的道路网络服务,包括道路检查、隐患和缺陷整改、应急响应和小型基建工程。 周二的交易中,该公司在澳大利亚和新西兰交易所的股票分别上涨了约 5% 和 2%。
Related Articles
Telix Pharmaceuticals' Investigational Imaging Agent May Potentially Diagnose a Range of Kidney Cancers
Telix Pharmaceuticals' (ASX:TLX) investigational imaging agent TLX250-Px has the potential to help diagnose kidney cancers beyond just clear cell renal cell carcinoma, or ccRCC, the company said Tuesday, citing an independent analysis published in the European Urology scientific journal.The analysis of phase three trial data showed that positive PET scan findings were "highly predictive" of malignancy overall, including in non-clear cell renal cell carcinoma, with a reported positive predictive value of 98%, the company said."Essentially all false-positives for ccRCC in the ZIRCON study have now been shown to be other malignant kidney cancer subtypes, reducing the risk of overtreatment and further supporting clinical adoption," said Telix Group Chief Medical Officer David Cade.
Huajin International Chairman, CEO Face Consumption Restriction Order
Huajin International (HKG:2738) said its chairman and chief executive were subject to a consumption restriction order due to the alleged nonpayment of amounts owed, according to a Hong Kong bourse filing Tuesday.The company's chairman Xu Songqing and chief executive Chen Chunniu have been subject to the consumption restriction order, effective Nov. 25.The case stems from the alleged non-payment of 130 million yuan by two of the company's units Jiangmen Huamu Metals and Jiangmen Huajin Metal Product, under a finance lease arrangement. As of April 30, 16.4 million yuan was still owed to the creditors.Both Xu and Chen have been negotiating with creditors to resolve the matter and the company expects to reach a settlement by the end of August.
Tata Chemicals' Consolidated Loss Widens in Fiscal Q4
Tata Chemicals' (NSE:TATACHEM, BOM:500770) consolidated attributable loss widened to 21.3 billion Indian rupees in the fiscal fourth quarter ended March 31, from a loss of 1.56 billion rupees a year ago.Loss per share grew to 83.68 rupees compared with a loss per share of 2.19 rupees a year earlier, the chemicals manufacturer said in a filing to the Indian bourses on Monday.Revenue from operations in fiscal Q4 declined to 34.4 billion rupees from 35.1 billion rupees a year ago. This was lower than the 34.8 billion rupees estimated by analysts polled by Visible Alpha.The company's board recommended a dividend of 11 rupees per share for the financial year ended March 31.